Errata

0-07-026266-7	Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 9th Edition
			Hardman and Limbird, Editors-in-Chief
			McGraw-Hill Health Professions Division

Page 23 (Digital book outline level 1.6.4.1.0.2 Caption for Figure 1-6)—“Average concentration (C‑) when the steady state is attained during intermittent drug administration.”  
The “C” should be directly under the “—“.

Page 334 (Digital book outline level 15.1.5, Caption for Figure 15-2)—The gray box following “...AMP-dependent protein kinase…” should be displayed as a “P” inside a circle.

Page 594 (Digital book outline level 25.4.2.2)— “Among the most important are the inhibitor of the activated first component of complement (C1–INH)”. 
The “—“ should be directly over the “1”.

Page 594 (Digital book outline level 25.4.2.4, Caption for Figure 25-3)— “The restraining effects of the complement inhibitor, C1 esterase inhibitor (C1–INH, "X"), are indicated. Other plasma proteinase inhibitors, such as plasmin, ∂2-macroglobulin, and ∂1-antitrypsin, act at some of the same sites. Besides being the primary inhibitor of plasma kallikrein, C1– INH also inhibits factor XIIa.Bradykinin and kallikrein”.
In both instances, the “—“ should be directly over the “1”.